About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $10.95 | Open | $10.94 |
| Volume | 176.1K | Market Cap | 1.571B |
| Yield | Last Dividend |
| EyePoint Pharmaceuticals Announces $16.5... | 12/18/20 |
| WATERTOWN, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing an... | |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) C... | 10/24/20 |
| Zacks Investment Research cut shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT) from a buy rating to a hold rating in a research report released on Wed... | |
| Investment Analysts??? Weekly Ratings Up... | 10/23/20 |
| A number of firms have modified their ratings and price targets on shares of Eyepoint Pharmaceuticals (NASDAQ: EYPT) recently: 10/21/2020 ??? Eyepoint... | |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) U... | 10/23/20 |
| Zacks Investment Research upgraded shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT) from a hold rating to a buy rating in a report released on Monday,... | |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) S... | 10/22/20 |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) was downgraded by Zacks Investment Research from a ???buy??? rating to a ???hold??? rating in a research note i... | |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) L... | 10/22/20 |
| Zacks Investment Research upgraded shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT) from a hold rating to a buy rating in a report published on Monday... | |
| The Daily Biotech Pulse: AbbVie In-licen... | 09/04/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3) Akouos Inc (NASDAQ: AKUS ) FibroGen Inc (NASDAQ: FGEN )(reacted to an adverse clinica... | |
| The Daily Biotech Pulse: Sanofi, GSK Beg... | 09/03/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (N... | |
| 60 Biggest Movers From Friday | 08/24/20 |
| Gainers Kymera Therapeutics, Inc. (NASDAQ: KYMR ) shares gained 66.3% to close at $33.26 on Friday after the company priced its 8.684 million share IP... | |
| EyePoint Pharmaceuticals News: Why EYPT ... | 08/21/20 |
| EyePoint Pharmaceuticals (EYPT) news from yesterday concerning a massive deal has EYPT stock continuing to climb higher on Friday. | |
| 34 Stocks Moving in Friday's Pre-Market ... | 08/21/20 |
| Gainers EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares rose 94.8% to $1.12 in pre-market trading. Eyepoint Pharmaceuticals shares gained around ... | |
| The Daily Biotech Pulse: Gilead's Filgot... | 08/19/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI )... | |
| Earnings Scheduled For August 5, 2020 | 08/05/20 |
| Companies Reporting Before The Bell ??? AmerisourceBergen Inc. (NYSE: ABC ) is expected to report quarterly earnings at $1.56 per share on revenue of ... | |
| EyePoint Pharmaceuticals and Harrow Heal... | 08/04/20 |
| \- Collaboration to bring DEXYCU to ImprimisRx???s established customer base of ophthalmologists, hospitals, and ambulatory surgical centers -WATERTOW... | |
| EyePoint Pharmaceuticals Expands Executi... | 07/13/20 |
| - World-renowned retina specialist to lead EYP-1901 development efforts and support expansion of EyePoint???s ocular disease pipeline - WATERTOWN, Mas... | |
| EyePoint Pharmaceuticals Presents Data S... | 05/18/20 |
| WATERTOWN, Mass., May 18, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and... | |
| EyePoint Pharmaceuticals Reports First Q... | 05/06/20 |
| - Total revenues of $7.5 million and net product revenues of $4.7 million - - Cash conservation and reorganization initiatives coupled??? | |
| The Daily Biotech Pulse: Fate Therapeuti... | 04/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BEL... | |
| The Daily Biotech Pulse: Mylan Ramps Up ... | 03/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) ... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| EyePoint Pharma +6% on Q4 beat | 03/05/20 |
| EyePoint Pharmaceuticals (EYPT) Q4 results: Revenues: $8.6M (+258.3%); Product sales: $7.9M. Net loss: ($10.4M) (+10.3%); loss/share: ($0.10) (+16.7%)... | |
| EyePoint Pharma inks exclusive license d... | 02/03/20 |
| EyePoint Pharmaceuticals (NASDAQ:EYPT) +11% after-hours on news it signed an exclusive license agreement with Equinox Science to develop vorolanib, a ... | |
| Revisiting EyePoint Pharmaceuticals - Br... | 01/23/20 |
| Shareholders of EyePoint Pharmaceuticals (EYPT) have been treated to a wild ride in the market over the past several years. Despite the volatility in ... | |
| EyePoint Pharma +15% premarket on prelim... | 01/23/20 |
| EyePoint Pharmaceuticals (NASDAQ:EYPT) reports preliminary Q4 and FY 2019 revenues. Q4 total and net product revenues are estimated to be between $7.5... | |
| Eyepoint Pharmaceuticals Inc (NASDAQ:EYP... | 11/17/19 |
| Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) was the recipient of a large increase in short interest during the month of October. As of October 31st, th... | |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) D... | 11/08/19 |
| Eyepoint Pharmaceuticals (NASDAQ:EYPT) was downgraded by analysts at ValuEngine from a ???buy??? rating to a ???hold??? rating in a research note issu... | |
| 2 Candidates That Could Be the Next Biot... | 10/18/19 |
| Omeros Corp. and EyePoint Pharmaceuticals are two small biotech companies that each have promising treatments that could send their shares skyward???.... | |
| EyePoint Pharmaceuticals (EYPT) May Repo... | 07/31/19 |
| EyePoint Pharmaceuticals (EYPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Ge... | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | ($0.05)/ 10.54M |
| Actual (EPS/Rev.) | $-0.03/ $15.70 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| FEAT. MARVIN GAYE | JOHN KROLIKOWSKI JR | 62.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.